Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Mpt0e028
2. 1338320-94-7
3. T65l58fi65
4. (e)-3-[1-(benzenesulfonyl)-2,3-dihydroindol-5-yl]-n-hydroxyprop-2-enamide
5. 2-propenamide, 3-(2,3-dihydro-1-(phenylsulfonyl)-1h-indol-5-yl)-n-hydroxy-
6. Imofinostat
7. Unii-t65l58fi65
8. Imofinostat [inn]
9. Orb1706952
10. Schembl2511433
11. Mgtifsbcggazdb-vqhvlokhsa-n
12. Glxc-04031
13. Akos040742169
14. Ms-25283
15. Sy461501
16. Hy-124295
17. Cs-0086144
18. G16985
19. Q27289720
20. (e)-n-hydroxy-3-[1-(phenylsulfonyl)indolin-5-yl]acrylamide
21. (2e)-3-[1-(benzenesulfonyl)-2,3-dihydro-1h-indol-5-yl]-n-hydroxyprop-2-enamide
| Molecular Weight | 344.4 g/mol |
|---|---|
| Molecular Formula | C17H16N2O4S |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 95.1 |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 578 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
70
PharmaCompass offers a list of Imofinostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Imofinostat manufacturer or Imofinostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imofinostat manufacturer or Imofinostat supplier.
A Imofinostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imofinostat, including repackagers and relabelers. The FDA regulates Imofinostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imofinostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Imofinostat supplier is an individual or a company that provides Imofinostat active pharmaceutical ingredient (API) or Imofinostat finished formulations upon request. The Imofinostat suppliers may include Imofinostat API manufacturers, exporters, distributors and traders.
Imofinostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imofinostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Imofinostat GMP manufacturer or Imofinostat GMP API supplier for your needs.
A Imofinostat CoA (Certificate of Analysis) is a formal document that attests to Imofinostat's compliance with Imofinostat specifications and serves as a tool for batch-level quality control.
Imofinostat CoA mostly includes findings from lab analyses of a specific batch. For each Imofinostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imofinostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Imofinostat EP), Imofinostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imofinostat USP).